Skip to content
Disclosery

NEA Management Company, LLC

Follow

13F filer, CIK 1512848, TIMONIUM, MD

NEA Management Company, LLC reported $1,328,451,108 across 32 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14. Its ten largest share positions make up 81.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000897069-25-001334

Period
2025-06-30
Reported value
$1.33B
Holdings
32
Top 10 weight
81.33%
New
1
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ORICadded+1,923,076$19.5M
CELCadded+1,044,260$13.9M
TRVIadded+1,851,852$10.1M
OMDAnew+364,115$6.66M
ZBIOadded+119,771$1.16M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TEMexited-2,615,979-$126M
VERONA PHARMA PLCreduced-425,427-$40.2M
X4 PHARMACEUTICALS INCreduced-14,487,234-$27.5M
REGULUS THERAPEUTICS INCexited-6,467,802-$11.3M
DMexited-1,439,892-$7.07M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000897069-25-001334, largest first. % of portfolio is the value over $1,328,451,108, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ACLXARCELLX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,745,262 shares; 2024Q4: 3,745,262 shares; 2025Q1: 3,745,262 shares; 2025Q2: 3,745,262 shares 3,745,262$247M18.56%0Timeline
VERONA PHARMA PLCVERONA PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,584,753 shares; 2024Q4: 5,584,753 shares; 2025Q1: 2,688,565 shares; 2025Q2: 2,263,138 shares 2,263,138$214M16.11%-425,427
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,909,956 shares; 2024Q4: 2,909,956 shares; 2025Q1: 2,909,956 shares; 2025Q2: 2,909,956 shares 2,909,956$184M13.84%0Timeline
COURCOURSERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 12,867,769 shares; 2024Q4: 12,867,769 shares; 2025Q1: 12,867,769 shares; 2025Q2: 12,867,769 shares 12,867,769$113M8.49%0Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,587,854 shares; 2024Q4: 1,587,854 shares; 2025Q1: 1,587,854 shares; 2025Q2: 1,587,854 shares 1,587,854$77.2M5.81%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,370,376 shares; 2024Q4: 11,370,376 shares; 2025Q1: 11,370,376 shares; 2025Q2: 13,222,228 shares 13,222,228$72.3M5.44%+1,851,852Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 24,471,264 shares; 2024Q4: 24,471,264 shares; 2025Q1: 24,471,264 shares; 2025Q2: 24,471,264 shares 24,471,264$55.8M4.2%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,500,000 shares; 2024Q4: 1,566,081 shares; 2025Q1: 2,195,545 shares; 2025Q2: 4,118,621 shares 4,118,621$41.8M3.15%+1,923,076Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,614,486 shares; 2024Q4: 3,614,486 shares; 2025Q1: 3,614,486 shares; 2025Q2: 3,614,486 shares 3,614,486$41.2M3.1%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,692,298 shares; 2024Q4: 7,692,298 shares; 2025Q1: 7,692,298 shares; 2025Q2: 7,692,298 shares 7,692,298$34.7M2.61%0Timeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,969,834 shares; 2024Q4: 3,969,834 shares; 2025Q1: 3,969,834 shares; 2025Q2: 3,969,834 shares 3,969,834$33.6M2.53%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,250,001 shares; 2024Q4: 1,250,001 shares; 2025Q1: 1,250,001 shares; 2025Q2: 2,294,261 shares 2,294,261$30.6M2.31%+1,044,260Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,613,948 shares; 2024Q4: 2,613,948 shares; 2025Q1: 2,613,948 shares; 2025Q2: 2,733,719 shares 2,733,719$26.5M1.99%+119,771Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 18,093,034 shares; 2024Q4: 18,093,034 shares; 2025Q1: 18,093,034 shares; 2025Q2: 18,093,034 shares 18,093,034$22.3M1.68%0Timeline
NEUEHEALTH INCNEUEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,726,917 shares; 2024Q4: 2,726,917 shares; 2025Q1: 2,726,917 shares; 2025Q2: 2,726,917 shares 2,726,917$18.8M1.42%0
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,960,169 shares; 2024Q4: 1,960,169 shares; 2025Q1: 1,960,169 shares; 2025Q2: 1,960,169 shares 1,960,169$18.8M1.42%0Timeline
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,090,793 shares; 2024Q4: 1,090,793 shares; 2025Q1: 1,090,793 shares; 2025Q2: 1,090,793 shares 1,090,793$13.6M1.03%0Timeline
CSBRCHAMPIONS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,713,720 shares; 2024Q4: 1,713,720 shares; 2025Q1: 1,713,720 shares; 2025Q2: 1,713,720 shares 1,713,720$12.6M0.95%0Timeline
CVRXCVRX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,370,542 shares; 2024Q4: 2,026,083 shares; 2025Q1: 2,026,083 shares; 2025Q2: 2,026,083 shares 2,026,083$11.9M0.9%0Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,448,757 shares; 2024Q4: 4,448,757 shares; 2025Q1: 4,448,757 shares; 2025Q2: 4,448,757 shares 4,448,757$11M0.83%0Timeline
INOZYME PHARMA INCINOZYME PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,437,689 shares; 2024Q4: 2,437,689 shares; 2025Q1: 2,437,689 shares; 2025Q2: 2,437,689 shares 2,437,689$9.75M0.73%0
SNTISENTI BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 442,615 shares; 2024Q4: 442,615 shares; 2025Q1: 3,775,615 shares; 2025Q2: 3,775,615 shares 3,775,615$7.97M0.6%0Timeline
OMDAOMADA HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 364,115 shares 364,115$6.66M0.5%newTimeline
NKTXNKARTA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,568,781 shares; 2024Q4: 3,568,781 shares; 2025Q1: 3,568,781 shares; 2025Q2: 3,568,781 shares 3,568,781$5.92M0.45%0Timeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,462,586 shares; 2024Q4: 1,462,586 shares; 2025Q1: 1,462,586 shares; 2025Q2: 1,462,586 shares 1,462,586$4.67M0.35%0Timeline
ADAPYADAPTIMMUNE THERAPEUTICS PLC SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,079,778 shares; 2024Q4: 17,079,778 shares; 2025Q1: 17,079,778 shares; 2025Q2: 17,079,778 shares 17,079,778$4.09M0.31%0Timeline
SYBXSYNLOGIC INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,922,772 shares; 2024Q4: 2,922,772 shares; 2025Q1: 2,922,772 shares; 2025Q2: 2,922,772 shares 2,922,772$3.71M0.28%0Timeline
MRKRMARKER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,071,428 shares; 2024Q4: 1,625,678 shares; 2025Q1: 1,625,678 shares; 2025Q2: 1,625,678 shares 1,625,678$2.49M0.19%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 478,548 shares; 2025Q1: 478,548 shares; 2025Q2: 478,548 shares 478,548$1.14M0.09%0Timeline
X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 14,986,793 shares; 2024Q4: 14,986,793 shares; 2025Q1: 14,986,793 shares; 2025Q2: 499,559 shares 499,559$949K0.07%-14,487,234
IKENA ONCOLOGY INCIKENA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 600,063 shares; 2024Q4: 600,063 shares; 2025Q1: 600,063 shares; 2025Q2: 600,063 shares 600,063$804K0.06%0
UPWHEELS UP EXPERIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 106,125 shares; 2024Q4: 106,125 shares; 2025Q1: 106,125 shares; 2025Q2: 106,125 shares 106,125$114K0.01%0Timeline

Sold out in Q2 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
TEMTEMPUS AI INC2,615,979$126Mshares
REGULUS THERAPEUTICS INCREGULUS THERAPEUTICS INC6,467,802$11.3Mshares
DMDESKTOP METAL INC CLASS A COM1,439,892$7.07Mshares
BZFDBUZZFEED INC2,512,103$5.35Mshares
ALLAKOS INCALLAKOS INC6,147,260$1.4Mshares
AFMDQAFFIMED N V ORDINARY SHARES NE442,648$320Kshares
TUYATUYA INC0$0shares

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000897069-25-001334 base2025-08-14acceptance time not in the bulk data set